Background: Synovial sepsis is a frequent cause of morbidity and mortality in horses. Despite advances in diagnostics and treatments, persistent infection or chronic lameness can occur.
Objectives: To perform a scoping review to identify and evaluate the current evidence on the factors implicated in the success of treatment for synovial sepsis.
Study Design: Joanna Briggs Institute scoping review.
Methods: A protocol was registered, and a systematic literature search was performed on CAB abstracts, Medline, Scopus and Embase. Inclusion and exclusion criteria were developed and studies systematically reviewed against this. Studies relating to factors affecting treatment success following synovial sepsis were retained and data was extracted on study method, population characteristics and factors significantly associated with treatment outcome.
Results: In total, 2338 studies were identified, and 61 were included to full paper analysis. Eight papers reported significant factors, identifying 15 risk factors associated with two measurements of outcome, either survival and/or return to athletic function. The 15 factors were identified and categorised into pre-, intra- and post-operative factors. Risk factors that were identified included the number or type of synovial structures involved, the presence of pannus, tendon and bone pathology, and the use of systemic antimicrobials. There were many discrepancies in inclusion criteria of cases of synovial sepsis as well as measurement and description of outcome variables.
Main Limitations: Non-English language studies or conference proceedings were not included. Only small numbers of papers had similar findings.
Conclusions: Standardisation of inclusion criteria is essential to enable comparisons and analysis between studies on synovial sepsis. Future studies should use methodologies to reduce bias including multicentre and multinational studies, prospective study design and robust statistical modelling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/evj.13527 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk of orthopaedic implant infection during bacteraemia.
APMIS
January 2025
Department of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Article Synopsis
- - Orthopaedic implants can get infected through bacteria traveling from other body areas after surgery, with most research focusing on prosthetic joints and their common infection sources being skin, heart, and dental issues.
- - The likelihood of developing a periprosthetic joint infection (PJI) during bacteria spread is highest with Staphylococcus aureus and beta-haemolytic streptococci, ranging from 12% to 41% for PJI during Staphylococcus aureus bacteraemia (SAB).
- - There is limited data on the infection risk for other orthopaedic implants beyond prosthetic joints, and typically, only symptomatic infected implants are investigated further rather than asymptomatic ones.
Literature review and case report of septic arthritis and purpura fulminans leading to a child limb amputation as chickenpox complications.
Ann Med Surg (Lond)
September 2024
Al Quds University School of Medicine, Faculty of Medicine, Al Quds University, Palestine.
Introduction And Significance: Chickenpox, induced by the varicella-zoster virus (VZV), generally presents with an itchy rash and fluid-filled blisters. While complications such as pneumonia and sepsis are well-documented, occurrences of septic arthritis and purpura fulminans are exceedingly rare. Septic arthritis following varicella infection is infrequently reported and often attributed to .
View Article and Find Full Text PDFNative Joint Septic Arthritis.
Antibiotics (Basel)
June 2024
Department of Orthopaedic Surgery, Duke University School of Medicine, Durham, NC 27701, USA.
Native joint septic arthritis (NJSA) is a severe and rapidly progressing joint infection, predominantly bacterial but also potentially fungal or viral, characterized by synovial membrane inflammation and joint damage, necessitating urgent and multidisciplinary management to prevent permanent joint damage and systemic sepsis. Common in large joints like knees, hips, shoulders, and elbows, NJSA's incidence is elevated in individuals with conditions like rheumatoid arthritis, diabetes, immunosuppression, joint replacement history, or intravenous drug use. This review provides a comprehensive overview of NJSA, encompassing its diagnosis, treatment, antibiotic therapy duration, and surgical interventions, as well as the comparison between arthroscopic and open debridement approaches.
View Article and Find Full Text PDFPutative mRNA Biomarkers for the Eradication of Infection in an Equine Experimental Model of Septic Arthritis.
Vet Sci
July 2024
Department of Veterinary Pathology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK S7N 5B4, Canada.
Septic arthritis (SA) in horses has long-term health implications. The success of its resolution hinges on the implementation of early, aggressive treatment, which is often sustained over a prolonged period. Common diagnostic methods do not allow for the reliable detection of the eradication of joint infection.
View Article and Find Full Text PDFIntroduction: Silica-sprayed tubes (SSTs) are often used to transport synovial fluid samples in equine practice. They promote the coagulation of the sample. The objective of the study is to evaluate the effect of SST on bacterial culture.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!